365 related articles for article (PubMed ID: 34134525)
1. Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.
Fradley MG; Beckie TM; Brown SA; Cheng RK; Dent SF; Nohria A; Patton KK; Singh JP; Olshansky B
Circulation; 2021 Jul; 144(3):e41-e55. PubMed ID: 34134525
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiology Translational Considerations in Cardio-Oncology: QT and Beyond.
Alomar M; Fradley MG
J Cardiovasc Transl Res; 2020 Jun; 13(3):390-401. PubMed ID: 31673900
[TBL] [Abstract][Full Text] [Related]
3. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
4. Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association.
Tisdale JE; Chung MK; Campbell KB; Hammadah M; Joglar JA; Leclerc J; Rajagopalan B;
Circulation; 2020 Oct; 142(15):e214-e233. PubMed ID: 32929996
[TBL] [Abstract][Full Text] [Related]
5. Strategies to Prevent Cardiotoxicity.
Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmias and Other Electrophysiology Issues in Cancer Patients Receiving Chemotherapy or Radiation.
Viganego F; Singh R; Fradley MG
Curr Cardiol Rep; 2016 Jun; 18(6):52. PubMed ID: 27108362
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Cardio-Oncology: Development of Cancer Treatment-Related Cardiotoxicity and the Therapeutic Approach to Affected Patients.
Ryan TD; Nagarajan R; Godown J
Curr Treat Options Oncol; 2019 May; 20(7):56. PubMed ID: 31129800
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic Complications in Cancer Patients.
Lee DH; Chandrashekhar S; Fradley MG
Methodist Debakey Cardiovasc J; 2019; 15(4):282-288. PubMed ID: 31988689
[TBL] [Abstract][Full Text] [Related]
10. Arrhythmic Complications Associated with Cancer Therapies.
Pothineni NVK; Van Besien H; Fradley MG
Heart Fail Clin; 2022 Jul; 18(3):375-383. PubMed ID: 35718413
[TBL] [Abstract][Full Text] [Related]
11. Equity in Cardio-Oncology Care and Research: A Scientific Statement From the American Heart Association.
Addison D; Branch M; Baik AH; Fradley MG; Okwuosa T; Reding KW; Simpson KE; Suero-Abreu GA; Yang EH; Yancy CW;
Circulation; 2023 Jul; 148(3):297-308. PubMed ID: 37377045
[TBL] [Abstract][Full Text] [Related]
12. Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods.
Kuang Z; Kong M; Yan N; Ma X; Wu M; Li J
Curr Treat Options Oncol; 2024 May; 25(5):679-701. PubMed ID: 38676836
[TBL] [Abstract][Full Text] [Related]
13. Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association.
Gopinathannair R; Cornwell WK; Dukes JW; Ellis CR; Hickey KT; Joglar JA; Pagani FD; Roukoz H; Slaughter MS; Patton KK
Circulation; 2019 May; 139(20):e967-e989. PubMed ID: 30943783
[TBL] [Abstract][Full Text] [Related]
14. Role of the autonomic nervous system in modulating cardiac arrhythmias.
Shen MJ; Zipes DP
Circ Res; 2014 Mar; 114(6):1004-21. PubMed ID: 24625726
[TBL] [Abstract][Full Text] [Related]
15. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.
Herrmann J
Nat Rev Cardiol; 2020 Aug; 17(8):474-502. PubMed ID: 32231332
[TBL] [Abstract][Full Text] [Related]
16. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GYH; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM;
Eur Heart J; 2016 Sep; 37(36):2768-2801. PubMed ID: 27567406
[No Abstract] [Full Text] [Related]
17. Electrophysiologic Toxicity of Chemoradiation.
Armanious MA; Mishra S; Fradley MG
Curr Oncol Rep; 2018 Apr; 20(6):45. PubMed ID: 29644475
[TBL] [Abstract][Full Text] [Related]
18. Arrhythmias in the intensive care patient.
Trappe HJ; Brandts B; Weismueller P
Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity of Contemporary Breast Cancer Treatments.
Lee Chuy K; Yu AF
Curr Treat Options Oncol; 2019 May; 20(6):51. PubMed ID: 31073788
[TBL] [Abstract][Full Text] [Related]
20. Arrhythmias and device therapies in patients with cancer therapy-induced cardiomyopathy.
Lee C; Maan A; Singh JP; Fradley MG
Heart Rhythm; 2021 Jul; 18(7):1223-1229. PubMed ID: 33640446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
